Is it time for immunopsychiatry in psychotic disorders? (Q38779149)

6 September 2017

title

Is it time for immunopsychiatry in psychotic disorders? (English)

1 reference

6 September 2017

1 reference

José Oliveira

2

0 references

Marion Leboyer

object named as

Marion Leboyer

series ordinal

1

0 references

Laurent Groc

series ordinal

4

object named as

Laurent Groc

1 reference

6 September 2017

Ryad Tamouza

3

1 reference

6 September 2017

publication date

18 March 2016

1 reference

6 September 2017

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

6 September 2017

volume

233

1 reference

6 September 2017

issue

9

1 reference

6 September 2017

page(s)

1651-1660

1 reference

Herpes simplex virus encephalitis is a trigger of brain autoimmunity.

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Glutamate receptor dynamics and protein interaction: Lessons from the NMDA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

The HPA axis in bipolar disorder: Systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Meta-Analysis of Cytokines and Chemokines in Suicidality: Distinguishing Suicidal Versus Nonsuicidal Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Bipolar disorder and antithyroid antibodies: review and case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Further Evidence of Relation Between Prenatal Famine and Major Affective Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Serological documentation of maternal influenza exposure and bipolar disorder in adult offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Obstetric complications and schizophrenia: historical and meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Anti-purkinje cell and natural autoantibodies in a group of psychiatric patients. Evidences for a correlation with the psychopathological status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Childhood maltreatment and inflammatory markers: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Neuroinflammation in suicide: Toward a comprehensive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Comorbidities and mortality in bipolar disorder: a Swedish national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Adverse childhood experiences, allostasis, allostatic load, and age-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

C-reactive protein alterations in bipolar disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

The HLA-G low expressor genotype is associated with protection against bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Antibodies to Toxoplasma gondii in individuals with mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Melancholic microbes: a link between gut microbiota and depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Association of schizophrenia and autoimmune diseases: linkage of Danish national registers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Childhood trauma is associated with severe clinical characteristics of bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Reconsidering the association between the major histocompatibility complex and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Bipolar and panic disorders may be associated with hereditary defects in the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

The "psychomicrobiotic": Targeting microbiota in major psychiatric disorders: A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Genetics of Schizophrenia: New Findings and Challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Sleep in patients with remitted bipolar disorders: a meta-analysis of actigraphy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Metabolic syndrome in a French cohort of patients with bipolar disorder: results from the FACE-BD cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Urinary tract infections in acute psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Neuropsychiatric presentations of antiphospholipid antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Human endogenous retroviral pol RNA and protein detected and identified in the blood of individuals with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Chronic bacterial infection activates autoreactive B cells and induces isotype switching and autoantigen-driven mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Plasma and cerebrospinal fluid interleukin-1 beta and interleukin-6 in hospitalized schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Genetics of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Prenatal stress and affective disorders in a population birth cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Anti-NMDA receptor encephalitis with the initial presentation of psychotic mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Single-molecule imaging of the functional crosstalk between surface NMDA and dopamine D1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Life expectancy and cardiovascular mortality in persons with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Can bipolar disorder be viewed as a multi-system inflammatory disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Human endogenous retrovirus type W (HERV-W) in schizophrenia: a new avenue of research at the gene-environment interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

DNA methylation reprogramming in the germ line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

The metabolic syndrome in schizophrenia: is inflammation a contributing cause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Acute maternal stress in pregnancy and schizophrenia in offspring: a cohort prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Circulating anti-brain autoantibodies in schizophrenia and mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Comorbidity in bipolar disorder: a framework for rational treatment selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Psychiatric Symptoms in Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Individual and familial risk factors for bipolar affective disorders in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Transactivation of elements in the human endogenous retrovirus W family by viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Association between toll-like receptor 2 gene diversity and early-onset bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Gestational influenza and bipolar disorder in adult offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Toll-like receptor-2 deficiency induces schizophrenia-like behaviors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Infection and autoimmunity: Lessons of animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Molecular characteristics of Human Endogenous Retrovirus type-W in schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Effects of antipsychotic drugs on cytokine networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Cytomegalovirus Antibody Elevation in Bipolar Disorder: Relation to Elevated Mood States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Biological insights from 108 schizophrenia-associated genetic loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Gastrointestinal inflammation and associated immune activation in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Activation of brain interleukin-1beta in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Is bipolar disorder an inflammatory condition? The relevance of microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Seasonality of births in schizophrenia and bipolar disorder: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Are some cases of psychosis caused by microbial agents? A review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Polymorphism of Toll-like receptor 4 gene in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Evidence for an Interaction Between Familial Liability and Prenatal Exposure to Infection in the Causation of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-016-4266-1

Common variants on chromosome 6p22.1 are associated with schizophrenia

21 January 2018

1 reference

12 December 2020

Methylation of endogenous human retroelements in health and disease.

1 reference

12 December 2020

Psychiatric manifestations of neurologic disease: where are we headed?

1 reference

12 December 2020

Combined effect of TLR2 gene polymorphism and early life stress on the age at onset of bipolar disorders

1 reference

12 December 2020

Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.

1 reference

12 December 2020

From neuroprogression to neuroprotection: implications for clinical care.

1 reference

12 December 2020

Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients

1 reference

12 December 2020

The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses

1 reference

12 December 2020

Preferential association between childhood emotional abuse and bipolar disorder

1 reference

12 December 2020

Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients

1 reference

12 December 2020

Common variants conferring risk of schizophrenia

1 reference

12 December 2020

High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder

1 reference

12 December 2020

The activation of monocyte and T cell networks in patients with bipolar disorder

1 reference

12 December 2020

Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia

1 reference

12 December 2020

Pentraxin 3 is reduced in bipolar disorder

1 reference

12 December 2020

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

1 reference

12 December 2020

Endogenous retroviruses in the human genome sequence

1 reference

12 December 2020

Elevated levels of human endogenous retrovirus-W transcripts in blood cells from patients with first episode schizophrenia.

1 reference

12 December 2020

Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies

1 reference

12 December 2020

Psychiatric symptoms in systemic lupus erythematosus: a systematic review

1 reference

12 December 2020

10.1007/S00213-016-4266-1

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1021002300

0 references

1 reference